Journal
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
Volume 32, Issue 8, Pages 911-918Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/03639040600814676
Keywords
Valdecoxib; nanosturctured lipid carriers (NLC); topical; anti-inflammatory; prolonged action
Categories
Ask authors/readers for more resources
Nanostructured Lipid Carrier (NLC)-based topical gel of Valdecoxib was formulated with the aim of faster onset yet prolonged action for the treatment of inflammation and allied conditions. NLCs prepared by microemulsion template technique were characterized by photon correlation spectroscopy for size. Drug encapsulation efficiency was determined using Nanosep(R) centrifugal device. The nanoparticulate dispersion was suitably gelled and characterized with respect to drug content, pH, spreadibility, rheology, and in-vitro release. Safety of the NLC-based gel was assessed using primary skin irritation studies, and efficacy was confirmed using pharmacodynamic study, namely the Aerosil-induced Rat Paw edema model. The developed NLC-based gel showed faster onset and elicited prolonged activity up to 24 hours.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available